The peripheral generation of CD4+ CD25+ regulatory T cells

Immunology

Volumn 109, Issue 3, 2003, Pages 319-325

  Akbar, Arne N ^a   Taams, Leonie S ^b   Salmon, Mike ^c   Vukmanovic Stejic, Milica ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR;

APOPTOSIS; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; LYMPHOCYTE DIFFERENTIATION; PHENOTYPE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; THYMUS;

APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CLONAL ANERGY; HUMANS; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTE SUBSETS; THYMUS GLAND;

EID: 0038127077     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2003.01678.x     Document Type: Review

References (73)

1. Dutton RW, Bradley LM, Swain SL. T cell memory. Annu Rev Immunol 1998; 16:201-23.
2. Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector and memory immune responses. Annu Rev Immunol 2000; 593:620-45.
3. Akbar AN, Salmon M, Savill J, Janossy G. A possible role for bcl-2 in regulating T cell memory-a 'balancing act' between cell death and survival. Immunol Today 1993; 14:526-31.
4. Ahmed R, Gray D. Immunological memory and protective immunity. Understanding their relation. Science 1996; 272:54-60.
5. Salmon M, Pilling D, Borthwick NJ, Viner N, Janossy G, Bacon PA, Akbar AN. The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis. Eur J Immunol 1994; 24:892-9.
6. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 1999; 162:5317-26.
7. + T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001; 193:1285-94.
8. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 2001; 193:1295-302.
9. + regulatory cells that control intestinal inflammation. J Exp Med 2000; 192:295-302.
10. + T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol 2001; 31:1122-31.
11. + T cells with regulatory properties from human blood. J Exp Med 2001; 193:1303-10.
12. Effros RB, Pawelec G. Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion? Immunol Today 1997; 18:450-4.
13. Pan C, Xue BH, Ellis TM, Peace DJ, Diaz MO. Changes in telomerase activity and telomere length during human T lymphocyte senescence. Exp Cell Res 1997; 231:346-53.
14. Allsopp RC, Chang E, Kashefi-Aazam M, Rogaev EI, Piatyszek MA, Shay J, Harley CB. Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res 1995; 220:194-200.
15. Rufer N, Brummendorf TH, Kolvraa S, Bischoff C, Christensen K, Wadsworth L, Schulzer M, Lansdorp PM. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J Exp Med 1999; 190:157-67.
16. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994; 91:9857-60.
17. Bodnar AG, Kim NW, Effros RB, Chiu CP. Mechanism of telomerase induction during T cell activation. Exp Cell Res 1996; 228:58-64.
18. Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB. Telomere end-replication problem and cell aging. J Mol Biol 1992; 225:951-60.
19. Rufer N, Dragowska W, Thornbury G, Roosnek E, Lansdorp PM. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat Biotechnol 1998; 16:743-7.
20. Weng NP, Levine BL, June CH, Hodes RJ. Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc Natl Acad Sci USA 1995; 92:11091-4.
21. Weng NP, Hodes RJ. The role of telomerase expression and telomere length maintenance in human and mouse. J Clin Immunol 2000; 20:257-67.
22. Weng NP, Hathcock KS, Hodes RJ. Regulation of telomere length and telomerase in T and B cells: a mechanism for maintaining replicative potential. Immunity 1998; 9:151-7.
23. Weng NP, Palmer LD, Levine BL, Lane HC, June CH, Hodes RJ. Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging. Immunol Rev 1997; 160:43-54.
24. Taams LS, Vukmanovic-Stejic M, Smith J et al. Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur J Immunol 2002; 32:1621-30.
25. Akbar AN, Borthwick N, Salmon M et al. The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J Exp Med 1993; 178:427-38.
26. s) gene expression. Eur J Immunol 1996; 26:294-9.
27. Vella AT, Dow S, Potter TA, Kappler J, Marrack P. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc Natl Acad Sci USA 1998; 95:3810-15.
28. Lenardo M, Chan KM, Hornung F, McFarland H, Siegel R, Wang J, Zheng L. Mature T lymphocyte apoptosis - immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol 1999; 17:221-53.
29. Pilling D, Akbar AN, Girdlestone J et al. Interferon β mediates stromal cell rescue of T cells from apoptosis. Eur J Immunol 1999; 29:1041-50.
30. Marrack P, Kappler J, Mitchell T. Type I interferons keep activated T cells alive. J Expl Med 1999; 189:521-9.
31. Scheel-Toellner D, Pilling D, Akbar AN, Hardie D, Lombardi G, Salmon M, Lord JM. Inhibition of T cell apoptosis by IFN-beta rapidly reverses nuclear translocation of protein kinase C-delta. Eur J Immunol 1999; 29:2603-12.
32. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001; 2:816-22.
33. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000; 101:455-8.
34. + suppressor T cells: more questions than answers. Nat Rev Immunol 2002; 2:389-400.
35. + thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 2001; 31:1247-54.
36. - subpopulations. J Immunol 2000; 165:3105-10.
37. Papiernik M, de Moraes ML, Pontoux C, Vasseur F, Penit C. Regulatory CD4 T cells, expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int Immunol 1998; 10:371-8.
38. Saoudi A, Seddon B, Fowell D, Mason D. The thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into prediabetic recipients. J Exp Med 1996; 184:2393-8.
39. Sakaguchi S, Takahashi T, Nishizuka Y. Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer. J Exp Med 1982; 156:1565-76.
40. Sakaguchi S, Takahashi T, Nishizuka Y. Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer. J Exp Med 1982; 156:1577-86.
41. Singh B, Read S, Asseman C, Malmstrom V et al. Control of intestinal inflammation by regulatory T cells. Immunol Rev 2001; 182:190-200.
42. Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 1996; 184:387-96.
43. + CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol 2001; 167:188-95.
44. + regulatory T cells by oral antigen administration. J Immunol 2001; 167:4245-53.
45. Taguchi O, Kontani K, Ikeda H, Kezuka T, Takeuchi M, Takahashi T, Takahashi T. Tissue-specific suppressor T cells involved in self-tolerance are activated extrathymically by self-antigens. Immunology 1994; 82:365-9.
46. Chen ZK, Cobbold SP, Waldmann H, Metcalfe S. Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation 1996; 62:1200-6.
47. + regulatory cells? Immunity 2001; 14:399-406.
48. + suppressor T cells that are not dependent upon IL-4. J Immunol 1998; 161:5147-56.
49. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000; 192:1213-22.
50. Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001; 167:1945-53.
51. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002; 195:603-16.
52. Lombardi G, Sidhu S, Batchelor R, Lechler R. Anergic T cells as suppressor cells in vitro. Science 1994; 264:1587-9.
53. Lombardi G, Hargreaves R, Sidhu S et al. Antigen presentation by T cells inhibits IL-2 production and induces IL-4 release due to altered cognate signals. J Immunol 1996; 156:2769-75.
54. Lamb JR, Skidmore BJ, Green N, Chiller JM, Feldmann M. Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J Exp Med 1983; 157:1434-47.
55. Ko HS, Fu SM, Winchester RJ, Yu DT, Kunkel HG. Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells. J Exp Med 1979; 150:246-55.
56. LaSalle JM, Tolentino PJ, Freeman GJ, Nadler LM, Hafler DA. Early signaling defects in human T, cells anergized by T, cell presentation of autoantigen. J Exp Med 1992; 176:177-86.
57. Taams LS, van Eden W, Wauben MH. Antigen presentation by T cells versus professional antigen-presenting cells (APC): differential consequences for T cell activation and subsequent T cell-APC interactions. Eur J Immunol 1999; 29:1543-50.
58. Broeren CP, Wauben MH, Lucassen MA, Van Meurs M, Van Kooten PJ, Boog CJ, Claassen E, van Eden W. Activated rat T cells synthesize and express functional major histocompatibility class II antigens. Immunology 1995; 84:193-201.
59. + T cells. J Immunol 2000; 165:3782-9.
60. + cells: a naturally occurring population of regulatory T cells. Blood 2001; 98:2736-44.
61. + T cells in thymus, cord and adult blood. Immunology 2002; 106:190-9.
62. + T cell numbers. J Immunol 2002; 169:4850-60.
63. + regulatory T cells. Nat. Immunol 2003; 4:330-6.
64. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057-61.
65. Bach JF. Regulatory T cells under scrutiny. Nat Rev Immunol 2003; 3:189-98.
66. Hayday A, Tigelaar R. Immunoregulation in the tissues by γδ T cells. Nat Rev Immunol 2003; 3:233-42.
67. Hargreaves RG, Borthwick NJ, Montani MG, Piccolella E, Carmichael P, Lechler RI, Akbar AN, Lombardi G. Dissociation of T cell anergy from apoptosis by blockade of Fas/Apo-1 (CD95) signaling. J Immunol 1997; 158:3099-107.
68. Schwartz RH. T cell anergy. Annu Rev Immunol 2003; 21:305-54.
69. Taams LS, van Eden W, Wauben MH. Dose-dependent induction of distinct anergic phenotypes: multiple levels of T cell anergy. J Immunol 1999; 162:1974-81.
70. Chai JG, Bartok I, Chandler P, Vendetti S, Antoniou A, Dyson J, Lechler R. Anergic T cells act as suppressor cells in vitro and in vivo. Eur J Immunol 1999; 29:686-92.
71. Hayashi RJ, Loh DY, Kanagawa O, Wang F. Differences between responses of naive and activated T cells to anergy induction. J Immunol 1998; 160:33-8.
72. + T cells. J Immunol 1997; 159:5853-61.
73. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998; 10:1969-80.